Most newer schizophrenia drugs no better: study
20th Sep 2005, 00:39 GMT
BOSTON (Reuters) - The first direct comparison of five schizophrenia drugs found that most newer treatments are no better than an older generic drug, despite their higher cost, a U.S. study released on Monday showed.
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study